| Valganciclovir for symptomatic congenital cytomegalovirus disease DW Kimberlin, PM Jester, PJ Sánchez, A Ahmed, R Arav-Boger, ... New England Journal of Medicine 372 (10), 933-943, 2015 | 797 | 2015 |
| Outcomes in transplant recipients treated with foscarnet for ganciclovir-resistant or refractory cytomegalovirus infection RK Avery, R Arav-Boger, KA Marr, E Kraus, S Shoham, L Lees, ... Transplantation 100 (10), e74-e80, 2016 | 147 | 2016 |
| Polymorphisms of the Cytomegalovirus (CMV)–Encoded Tumor Necrosis Factor–α and β-Chemokine Receptors in Congenital CMV Disease R Arav-Boger, RE Willoughby, RF Pass, JC Zong, WJ Jang, D Alcendor, ... The Journal of infectious diseases 186 (8), 1057-1064, 2002 | 147 | 2002 |
| Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention RF Pass, R Arav-Boger F1000Research 7, 2018 | 135 | 2018 |
| Urinary tract infections with low and high colony counts in young women: spontaneous remission and single-dose vs multiple-day treatment R Arav-Boger, L Leibovici, YL Danon Archives of Internal Medicine 154 (3), 300-304, 1994 | 93 | 1994 |
| Cytomegalovirus (CMV)–Encoded UL144 (Truncated Tumor Necrosis Factor Receptor) and Outcome of Congenital CMV Infection R Arav-Boger, CA Battaglia, T Lazzarotto, L Gabrielli, JC Zong, ... The Journal of infectious diseases 194 (4), 464-473, 2006 | 80 | 2006 |
| Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient R Arav-Boger, M Echavarria, M Forman, P Charache, D Persaud The Pediatric infectious disease journal 19 (11), 1097-1100, 2000 | 80 | 2000 |
| Molecular mechanisms of resistance in antimalarial chemotherapy: the unmet challenge R Arav-Boger, TA Shapiro Annu. Rev. Pharmacol. Toxicol. 45, 565-585, 2005 | 79 | 2005 |
| Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells L D'Aiuto, R Di Maio, B Heath, G Raimondi, J Milosevic, AM Watson, ... PLoS One 7 (11), e49700, 2012 | 78 | 2012 |
| An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities R He, BT Mott, AS Rosenthal, DT Genna, GH Posner, R Arav-Boger PloS one 6 (8), e24334, 2011 | 71 | 2011 |
| Portal vein thrombosis caused by protein C and protein S deficiency associated with cytomegalovirus infection R Arav-Boger, S Reif, Y Bujanover The Journal of pediatrics 126 (4), 586-588, 1995 | 69 | 1995 |
| Absence of Cytomegalovirus in Glioblastoma and Other High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ Hybridization M Holdhoff, G Guner, FJ Rodriguez, JL Hicks, Q Zheng, MS Forman, X Ye, ... Clinical Cancer Research 23 (12), 3150-3157, 2017 | 66 | 2017 |
| Activation of nucleotide oligomerization domain 2 (NOD2) by human cytomegalovirus initiates innate immune responses and restricts virus replication A Kapoor, M Forman, R Arav-Boger PloS one 9 (3), e92704, 2014 | 64 | 2014 |
| Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene A Kapoor, H Cai, M Forman, R He, M Shamay, R Arav-Boger Antimicrobial agents and chemotherapy 56 (9), 4891-4899, 2012 | 64 | 2012 |
| Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers R Arav-Boger, R He, CJ Chiou, J Liu, L Woodard, A Rosenthal, ... PLoS One 5 (4), e10370, 2010 | 64 | 2010 |
| Human Cytomegalovirus–Encoded α-Chemokines Exhibit High Sequence Variability in Congenitally Infected Newborns R Arav-Boger, CB Foster, JC Zong, RF Pass The Journal of infectious diseases 193 (6), 788-791, 2006 | 61 | 2006 |
| In Vitro Combination of Anti-Cytomegalovirus Compounds Acting through Different Targets: Role of the Slope Parameter and Insights into Mechanisms of Action H Cai, A Kapoor, R He, R Venkatadri, M Forman, GH Posner, ... Antimicrobial agents and chemotherapy 58 (2), 986-994, 2014 | 60 | 2014 |
| Efficacy and mechanism of action of low dose emetine against human cytomegalovirus R Mukhopadhyay, S Roy, R Venkatadri, YP Su, W Ye, E Barnaeva, ... PLoS pathogens 12 (6), e1005717, 2016 | 59 | 2016 |
| Wnt modulating agents inhibit human cytomegalovirus replication A Kapoor, R He, R Venkatadri, M Forman, R Arav-Boger Antimicrobial agents and chemotherapy 57 (6), 2761-2767, 2013 | 58 | 2013 |
| Blood viral load in symptomatic congenital cytomegalovirus infection C Marsico, I Aban, H Kuo, SH James, PJ Sanchez, A Ahmed, ... The Journal of Infectious Diseases 219 (9), 1398-1406, 2019 | 48 | 2019 |
